---
linkTitle: 01-15-æ—¥æŠ¥
title: BioAI ç”Ÿå‘½ç§‘å­¦æ—¥æŠ¥ 2026/1/15
weight: 17
breadcrumbs: false
comments: true
description: "æ¯æ—¥è‡ªåŠ¨æ±‡æ€»æœ€æ–° AI è¡Œä¸šåŠ¨æ€ï¼Œå¸®ä¸­æ–‡ç”¨æˆ·ç”¨æœ€ä½æˆæœ¬ç©è½¬ChatGPTã€Claudeã€Cursorã€Augment ç­‰ AI å·¥å…·ã€‚ç”±çˆ±çªå•¦ AI è´¦å·åº—æä¾›æ”¯æŒã€‚"
---

## **ä»Šæ—¥æ‘˜è¦**

```
**Processing the Inputs**

I'm currently dissecting the provided content, focusing on identifying the core events. My initial analysis pinpoints "Boltz-2" as a significant highlight, and I'm sifting for the critical details to synthesize the three-line summary the user requests. The goal is to encapsulate the essence of these scientific developments.


**Refining the Summary**

I'm now zeroing in on the "three-line summary" directive. I've drafted a line emphasizing Boltz-2's impact and am now focusing on the second line. Considering the "new trends," I'm exploring how to best incorporate the multi-agent protein design approach and other interesting project mentions in an informative way. I aim to strike a balance between brevity and detail.


**Constructing the Synthesis**

I'm now integrating the three lines, ensuring conciseness and clarity for the final draft. The first line is solidified, highlighting Boltz-2's impact. I've chosen option B for the second line, leaning towards application-focused, and rephrased it for rhythm. The final line synthesizes the technological shift. I am aiming for a readable and informative summary.


**Synthesizing the Information**

I have finalized the three-line summary. The first line highlights Boltz-2's impressive performance. The second line encapsulates the new trends, featuring Nature's enzyme design work, alongside the agent-based protein design approach. The third line summarizes the impact of these developments on the industry, anticipating cost reductions. The synthesis is complete and ready.


**Refining Final Output**

I'm now polishing the final version, focusing on impactful language and readability. The three-line structure is set, and I'm ensuring conciseness and clarity in each line. I've re-evaluated word choices to enhance the overall impact. I've double-checked the word count for compliance and I am ready to submit the final summary.


**Summarizing the Essence**

I'm now carefully reviewing and finalizing the three-line summary. The focus is on ensuring each line is concise, informative, and impactful, while adhering to the user's specific guidelines regarding length and tone. Word choices have been revisited to convey the essence of the report's key takeaways. I am very confident this final version is ready for submission.


Boltz-2 åˆ·æ–°è™šæ‹Ÿè¯ç‰©ç­›é€‰çºªå½•ï¼Œå‡†ç¡®ç‡æ˜¯ç«å“ä¸¤å€ï¼Œæ¹¿å®éªŒéªŒè¯å…šç‹‚å–œã€‚
Nature åˆŠç™»ç”Ÿæˆå¼é…¶è®¾è®¡çªç ´ï¼Œè›‹ç™½è´¨è®¾è®¡èµ›é“å¼€å§‹æµè¡Œâ€œå¤šæ™ºèƒ½ä½“â€å›¢é˜Ÿåä½œã€‚
è™šæ‹Ÿç­›é€‰æˆæœ¬æœ‰æœ›è…°æ–©ï¼ŒAI for Science æ­£è¿æ¥å±äºå®ƒçš„â€œChatGPT æ—¶åˆ»â€ã€‚
```



## âš¡ å¿«é€Ÿå¯¼èˆª

- [ğŸ“° ä»Šæ—¥ AI èµ„è®¯](#ä»Šæ—¥aièµ„è®¯) - æœ€æ–°åŠ¨æ€é€Ÿè§ˆ



> ğŸ’¡ **æç¤º**ï¼šæƒ³ç¬¬ä¸€æ—¶é—´ä½“éªŒæ–‡ä¸­æåˆ°çš„æœ€æ–° AI æ¨¡å‹ï¼ˆClaude 4.5ã€GPTã€Gemini 3 Proï¼‰ï¼Ÿæ²¡æœ‰è´¦å·ï¼Ÿæ¥ [**çˆ±çªå•¦ Aivora**](https://aivora.cn?utm_source=daily_news&utm_medium=mid_ad&utm_campaign=content) é¢†ä¸ªå·ï¼Œä¸€åˆ†é’Ÿä¸Šæ‰‹ï¼Œå”®åæ— å¿§ã€‚

**Examining Newsletter Goals**

I'm currently focused on defining the newsletter's core purpose. Specifically, I'm analyzing the requested role of AI expert and the intended audience, which includes investors and practitioners in the AI and Life Sciences fields. The goal is to identify their primary needs and interests to create a valuable and relevant newsletter.


**Evaluating Information Relevance**

I'm now deep-diving into the core of filtering and scoring the incoming news snippets. Evaluating their direct relevance to the AI + Bio intersection is proving crucial, especially within the context of the defined constraints. I'm formulating a scoring system to ensure only the most impactful and relevant information makes it to the final newsletter.


**Defining Content Selection Criteria**

I'm presently building the scoring system based on relevance, impact, and audience interest for each news item. The most recent focus has been evaluating the news snippets, assigning scores, and making placement decisions (TOP 10, Worth Watching, etc.). It's crucial to ensure the newsletter offers the most important news.


**Refining Selection Process**

I'm now prioritizing the final selection. I'm focusing on crafting a compelling narrative for the "TOP 10" section. Weighing each news snippet's AI and Bio relevance with my scoring system, ensuring the most impactful stories are highlighted. I'm also considering the "Worth Watching" category content, and drafting the FAQ section to give context to general readers.


**Prioritizing Content & Framing**

I'm now focusing on refining the TOP 10 selections, ensuring a balance of impact and novelty.  Drafting the short descriptions, using a conversational tone, and emphasizing the "shocking/useful/impactful" aspects. The aim is to create engaging summaries that highlight the core value of each piece of news. I will prioritize the "human" angle and narrative.


**Synthesizing Draft Content**

My current focus is converting the selected news snippets into engaging newsletter content. I am now working on the "TOP 10" section, using a conversational style and emphasizing the impact and novelty of each piece of news. I am also preparing "Worth Watching" content, grouping them by category. The final stage will be writing the fun, trends and FAQ sections.


**Synthesizing Draft Output**

I'm now consolidating the selection, refining the "TOP 10" entries to emphasize their impact. The descriptions will be conversational and engaging. I'm finalizing "Worth Watching," and writing the Fun, Trends, and FAQ sections. Prioritizing clarity and ensuring the final product adheres to all outlined constraints and specifications, while focusing on a human-centered narrative style.


**Synthesizing Draft Delivery**

I'm now structuring the output and starting the final draft. It involves refining the "TOP 10" entries, ensuring a compelling narrative for each, and grouping "Worth Watching." I'm writing the "Fun," "Trends," and "FAQ" sections, focusing on clarity, adherence to constraints, and a human-centered narrative style. I'm checking links, formatting, and tone before delivering the finished newsletter.


## **ä»Šæ—¥ AI ç”Ÿå‘½ç§‘å­¦èµ„è®¯**

### **ğŸ‘€ åªæœ‰ä¸€å¥è¯**
AI åœ¨è™šæ‹Ÿè¯ç‰©ç­›é€‰ï¼ˆVirtual Screeningï¼‰ä¸Šåˆæ€ç–¯äº†ï¼ŒBoltz-2 åœ¨æœ€æ–°æ®‹é…·æµ‹è¯•ä¸­å‡†ç¡®ç‡ç›´æ¥æ˜¯ç¬¬äºŒåçš„ä¸¤å€ï¼Œæ¹¿å®éªŒéªŒè¯å…šç‹‚å–œã€‚

### **ğŸ”‘ 3 ä¸ªå…³é”®è¯**
#AIè¯ç‰©ç­›é€‰ #ç”Ÿæˆå¼é…¶è®¾è®¡ #å¤šæ™ºèƒ½ä½“è›‹ç™½è´¨è®¾è®¡

## **ğŸ”¥ é‡ç£… TOP 6**

**âš ï¸ ç­›é€‰è¯´æ˜**ï¼šä»Šæ—¥ AI+Bio ç¡¬æ ¸å¹²è´§æ‰å †ï¼Œå°¤å…¶æ˜¯è¯ç‰©å‘ç°å’Œè›‹ç™½è´¨è®¾è®¡é¢†åŸŸã€‚æˆ‘ä»¬ç æ‰äº†æ‰€æœ‰å‡‘æ•°çš„é€šç”¨ AI æ–°é—»ï¼Œåªç•™æœ€å€¼å¾—çœ‹çš„ã€‚

### **[Boltz-2 æ€ç–¯äº†ï¼šè™šæ‹Ÿç­›é€‰å‡†ç¡®ç‡ç¢¾å‹å…¨åœº](https://www.biorxiv.org/content/10.64898/2026.01.14.699425v1?rss=1)**
**è¯„åˆ†ï¼š95åˆ† (æƒå¨æ€§/å½±å“åŠ›)**
**åœºæ™¯**ï¼šä»¥å‰åšè¯ç‰©è™šæ‹Ÿç­›é€‰ï¼Œå°±åƒåœ¨å¹²è‰å †é‡Œæ‰¾é’ˆï¼Œè·‘å‡ºæ¥çš„ä¸€å †ç»“æœé‡Œå¤§éƒ¨åˆ†æ˜¯å‡é˜³æ€§ï¼ŒåŒ–å­¦å®¶çœ‹ä¸€çœ¼éƒ½æƒ³æ‰“äººã€‚
**çªç ´**ï¼šè¿™ç¯‡æ–°è®ºæ–‡æäº†ä¸ªâ€œåœ°ç‹±çº§éš¾åº¦â€çš„æµ‹è¯•â€”â€”åŸºäº10ä¸ªè¶…å¤§å‹è™šæ‹Ÿç­›é€‰å‘½ä¸­åˆ—è¡¨å’Œä½“å¤–ç»“åˆå®éªŒæ•°æ®ã€‚ç»“æœæ˜¾ç¤ºï¼Œ**Boltz-2 æ¨¡å‹çš„è¡¨ç°ç®€ç›´ç¦»è°±ï¼ŒæˆåŠŸç‡æ˜¯å…¶ä»–ä»»ä½•é‡æ‰“åˆ†ç­–ç•¥çš„ä¸¤å€**ã€‚
**ç‚¹è¯„**ï¼šä¸ä»…å‡†ï¼Œè¿˜å¿«ã€‚è¿™æ„å‘³ç€æœªæ¥æˆ‘ä»¬åœ¨ç™¾ä¸‡çº§åŒ–åˆç‰©åº“é‡Œæ‰¾è¯ï¼Œå¯èƒ½çœŸçš„åªéœ€è¦è·‘ä¸€ä¸‹è¿™ä¸ªæ¨¡å‹ï¼Œè€Œä¸æ˜¯å»çƒ§é’±åšé«˜é€šé‡ç­›é€‰äº†ã€‚ç”±è¯­è¨€æ¨¡å‹é©±åŠ¨çš„è›‹ç™½è´¨-é…ä½“ç›¸äº’ä½œç”¨é¢„æµ‹ï¼Œæ­£åœ¨è¿æ¥å®ƒçš„â€œChatGPT æ—¶åˆ»â€ã€‚

### **[Natureï¼šAI å‡­ç©ºè®¾è®¡å‡ºâ€œå…¨èƒ½â€è‰²æ°¨é…¸åˆé…¶](https://www.nature.com/articles/s41467-026-68384-6)**
**è¯„åˆ†ï¼š88åˆ† (Natureå­åˆŠ/ç”Ÿæˆå¼è®¾è®¡)**
**åœºæ™¯**ï¼šé…¶å·¥ç¨‹ä»¥å‰å…¨é â€œæ”¹â€ï¼Œåœ¨è‡ªç„¶ç•Œå·²æœ‰çš„é…¶ä¸Šä¿®ä¿®è¡¥è¡¥ã€‚æƒ³ä»é›¶è®¾è®¡ä¸€ä¸ªå¥½ç”¨çš„é…¶ï¼Ÿéš¾äºä¸Šé’å¤©ã€‚
**çªç ´**ï¼šç ”ç©¶å›¢é˜Ÿç”¨åŸºäºåºåˆ—çš„ç”Ÿæˆå¼ AIï¼Œç›´æ¥è®¾è®¡å‡ºäº†å…¨æ–°çš„è‰²æ°¨é…¸åˆé…¶ï¼ˆTrpBï¼‰ã€‚è¿™äº› AI è®¾è®¡çš„é…¶ä¸ä»…èƒ½ç”¨ï¼Œè€Œä¸”åœ¨**åº•ç‰©ç‰¹å¼‚æ€§ã€ç«‹ä½“é€‰æ‹©æ€§å’Œçƒ­ç¨³å®šæ€§**ä¸Šå±•ç°å‡ºäº†æƒŠäººçš„å¤šæ ·æ€§ã€‚
**ç‚¹è¯„**ï¼šè¿™è¯æ˜äº†ç”Ÿæˆå¼ AI å·²ç»ç†è§£äº†é…¶çš„â€œè¯­è¨€â€ã€‚å¯¹äºåˆæˆç”Ÿç‰©å­¦æ¥è¯´ï¼Œä»¥åç¼ºä»€ä¹ˆåŠŸèƒ½çš„é…¶ï¼Œå¯èƒ½ä¸å†éœ€è¦å»æ·±æµ·æˆ–ç«å±±å£æ‰¾èŒç§äº†ï¼Œç›´æ¥è®© AI ç”»ä¸€ä¸ªå°±è¡Œã€‚

### **[Natureï¼šè¡€ç³–æ•°æ®å¤ªå¤šçœ‹ä¸æ‡‚ï¼Ÿé¦–ä¸ª CGM åŸºç¡€æ¨¡å‹æ¥äº†](https://www.nature.com/articles/s41586-025-09925-9)**
**è¯„åˆ†ï¼š85åˆ† (ä¸´åºŠåº”ç”¨/åŸºç¡€æ¨¡å‹)**
**åœºæ™¯**ï¼šç°åœ¨æˆ´è¿ç»­è¡€ç³–ç›‘æµ‹ä»ªï¼ˆCGMï¼‰çš„äººè¶Šæ¥è¶Šå¤šï¼Œæ•°æ®æ˜¯æœ‰äº†ï¼Œä½†æ€ä¹ˆä»è¿™äº›æ³¢åŠ¨çš„æ›²çº¿é‡Œè¯»å‡ºå¥åº·é£é™©ï¼ŒåŒ»ç”Ÿä¹Ÿå¤´å¤§ã€‚
**çªç ´**ï¼šç ”ç©¶è€…å‘å¸ƒäº†ä¸€ä¸ªä¸“é—¨é’ˆå¯¹ CGM æ•°æ®çš„åŸºç¡€æ¨¡å‹ã€‚å®ƒä¸åƒä»¥å‰çš„å°æ¨¡å‹åªèƒ½åšç®€å•çš„é¢„æµ‹ï¼Œè¿™ä¸ªå¤§å®¶ä¼™èƒ½ç†è§£è¡€ç³–æ³¢åŠ¨çš„æ·±å±‚æ¨¡å¼ã€‚
**ç‚¹è¯„**ï¼šè¿™æ˜¯ AI åœ¨ä¸ªæ€§åŒ–åŒ»ç–—è½åœ°çš„å…¸å‹æ —å­ã€‚æœªæ¥çš„å¥åº·ç®¡ç†ï¼Œå¯èƒ½å°±æ˜¯ä½ æ‰‹ä¸Šçš„è®¾å¤‡é‡‡é›†æ•°æ®ï¼Œäº‘ç«¯çš„ AI åŸºç¡€æ¨¡å‹å®æ—¶å‘Šè¯‰ä½ ï¼šâ€œåˆ«åƒé‚£å£è›‹ç³•äº†ï¼Œä½ çš„èƒ°å²›ç´ æŠµæŠ—æ­£åœ¨æŠ¥è­¦ã€‚â€

### **[MAProtï¼šè›‹ç™½è´¨è®¾è®¡ä¹Ÿæâ€œå¤šæ™ºèƒ½ä½“â€åä½œ](https://www.biorxiv.org/content/10.64898/2026.01.13.699365v1?rss=1)**
**è¯„åˆ†ï¼š85åˆ† (å‰æ²¿æ¶æ„/å¤šæ™ºèƒ½ä½“)**
**åœºæ™¯**ï¼šè›‹ç™½è´¨è®¾è®¡æœ‰ä¸ªè€éš¾é¢˜ï¼šåšç»“æ„çš„ AI å®¹æ˜“è®¾è®¡å‡ºâ€œæŠ˜å å¾—å¥½ä½†æ²¡åŠŸèƒ½â€çš„åºŸæŸ´ï¼Œåšåºåˆ—çš„ AI å®¹æ˜“è®¾è®¡å‡ºâ€œæœ‰åŠŸèƒ½ä½†æŠ˜å ä¸èµ·æ¥â€çš„è½¯è„šè™¾ã€‚
**çªç ´**ï¼šMAProt å¼•å…¥äº†**å¤šæ™ºèƒ½ä½“å¼ºåŒ–å­¦ä¹ ï¼ˆMARLï¼‰**ã€‚ç®€å•è¯´å°±æ˜¯æäº†ä¸ªå›¢é˜Ÿï¼šä¸€ä¸ª Agent ä¸“æ”»ç»“æ„ç¨³å®šæ€§ï¼ˆåƒ ProteinMPNNï¼‰ï¼Œå¦ä¸€ä¸ª Agent ä¸“æ”»è¿›åŒ–åŠŸèƒ½ï¼ˆåƒ ESMï¼‰ï¼Œç„¶åé€šè¿‡åšå¼ˆå’Œåå•†è¾¾æˆå…±è¯†ã€‚
**ç‚¹è¯„**ï¼šè¿™ç§â€œå·¦æ‰‹ç”»æ–¹å³æ‰‹ç”»åœ†â€çš„ååŒä¼˜åŒ–ï¼Œåœ¨çƒ­ç¨³å®šæ€§ã€åŠŸèƒ½è®¾è®¡å’ŒæŠ—ä½“è®¾è®¡ä»»åŠ¡ä¸Šéƒ½æš´æ‰“äº†ç°æœ‰åŸºçº¿æ¨¡å‹ã€‚Agentic AIï¼ˆæ™ºèƒ½ä½“ AIï¼‰æœç„¶æ˜¯ä»Šå¹´çš„å¤§è¶‹åŠ¿ã€‚

### **[ç»™ç”Ÿç‰© LLM å¼€å¤–æŒ‚ï¼šæ¨ç†é€Ÿåº¦æå‡ 100%](https://www.biorxiv.org/content/10.64898/2026.01.13.699044v1?rss=1)**
**è¯„åˆ†ï¼š82åˆ† (åŸºç¡€è®¾æ–½/æ¨ç†åŠ é€Ÿ)**
**åœºæ™¯**ï¼šç”Ÿç‰©å¤§æ¨¡å‹ï¼ˆå¦‚ DNAGPT, ProGen2ï¼‰å¥½ç”¨æ˜¯å¥½ç”¨ï¼Œä½†ç”Ÿæˆé•¿åºåˆ—æ—¶æ…¢å¾—åƒèœ—ç‰›ï¼Œå°¤å…¶æ˜¯åœ¨å¤§è§„æ¨¡è›‹ç™½è´¨ç”Ÿæˆæ—¶ï¼Œæˆæœ¬é«˜å¾—å“äººã€‚
**çªç ´**ï¼šè¿™ç¯‡è®ºæ–‡æŠŠ**æŠ•æœºè§£ç ï¼ˆSpeculative Decodingï¼‰**æŠ€æœ¯æ¬åˆ°äº†åŸºå› ç»„åŸºç¡€æ¨¡å‹ä¸Šã€‚åŸç†å°±æ˜¯ç”¨ä¸€ä¸ªå°æ¨¡å‹å…ˆâ€œçŒœâ€å‡ ä¸ªè¯ï¼Œå¤§æ¨¡å‹å†è´Ÿè´£â€œæ‰¹æ”¹â€ï¼Œç»“æœåœ¨ä¸ç‰ºç‰²è´¨é‡çš„æƒ…å†µä¸‹ï¼Œæ¨ç†é€Ÿåº¦æœ€é«˜ç¿»å€ã€‚
**ç‚¹è¯„**ï¼šè¿™æ˜¯å…¸å‹çš„â€œå·¥ç¨‹ä¼˜åŒ–æ”¹å˜ç§‘ç ”ä½“éªŒâ€ã€‚å¯¹äºé‚£äº›éœ€è¦æ‰¹é‡ç”Ÿæˆæ•°ä¸‡ä¸ªè›‹ç™½è´¨åºåˆ—çš„å…¬å¸æ¥è¯´ï¼Œè¿™ç›´æ¥æ„å‘³ç€ç®—åŠ›æˆæœ¬å‡åŠã€‚

### **[è§£ç é»‘ç›’ï¼šä» AI æ¨¡å‹ä¸­æå–äººç±»èƒ½æ‡‚çš„åŸºå› è°ƒæ§è§„åˆ™](https://www.biorxiv.org/content/10.64898/2026.01.14.699402v1?rss=1)**
**è¯„åˆ†ï¼š80åˆ† (å¯è§£é‡Šæ€§/åŸºå› ç»„å­¦)**
**åœºæ™¯**ï¼šç°åœ¨çš„ Sequence-to-Function æ¨¡å‹é¢„æµ‹åŸºå› è¡¨è¾¾å¾ˆå‡†ï¼Œä½†é—®å®ƒâ€œä¸ºä»€ä¹ˆâ€ï¼Œå®ƒå°±åƒä¸ªé»‘ç›’å­ä¸€å£°ä¸å­ã€‚
**çªç ´**ï¼šç ”ç©¶è€…å¼€å‘äº† **TF-MINDI**ï¼Œä¸“é—¨ç”¨æ¥ä»è¿™äº›é»‘ç›’æ¨¡å‹é‡Œæå–é¡ºå¼è°ƒæ§è§„åˆ™ï¼ˆCis-regulatory rulesï¼‰ã€‚å®ƒä¸ä»…èƒ½é¢„æµ‹ï¼Œè¿˜èƒ½å‘Šè¯‰ä½ æ˜¯å› ä¸ºå“ªå‡ ä¸ªè½¬å½•å› å­ï¼ˆTFï¼‰ç»“åˆåœ¨ä¸€èµ·æ‰èµ·äº†ä½œç”¨ã€‚
**ç‚¹è¯„**ï¼šAI for Science ä¸ä»…è¦çŸ¥å…¶ç„¶ï¼Œè¿˜è¦çŸ¥å…¶æ‰€ä»¥ç„¶ã€‚è¿™ä¸ªå·¥å…·åœ¨äººç±»ç¥ç»å‘è‚²çš„ç ”ç©¶ä¸­å·²ç»éªŒè¯äº†æœ‰æ•ˆæ€§ï¼Œèƒ½å¸®ç”Ÿç‰©å­¦å®¶é‡æ–°æ¡å›å¯¹å®éªŒçš„æŒæ§æ„Ÿã€‚

## **ğŸ“Œ å€¼å¾—å…³æ³¨**

**[å·¥å…·] [OpenHealthï¼šä½ çš„å¼€æº AI å¥åº·åŠ©æ‰‹](https://github.com/OpenHealthForAll/open-health)**
Github ä¸Š 3.7k æ˜Ÿçš„é¡¹ç›®ï¼Œä¸»æ‰“æ•°æ®éšç§ï¼ŒæŠŠ AI å˜æˆäº†èƒ½è¯»æ‡‚ä½ å¥åº·æ¡£æ¡ˆçš„ç§äººåŒ»ç”Ÿï¼Œå€¼å¾—æå®¢ä»¬æŠ˜è…¾ä¸€ä¸‹ã€‚

**[ç ”ç©¶] [Spa3Dï¼šæŠŠç©ºé—´è½¬å½•ç»„å˜æˆ 3D çš„](https://www.biorxiv.org/content/10.64898/2026.01.13.699328v1?rss=1)**
ä»¥å‰çœ‹åˆ‡ç‰‡æ˜¯äºŒç»´çš„ï¼Œç°åœ¨ç”¨å›¾ç¥ç»ç½‘ç»œé‡æ„å‡º 3D ç»“æ„ã€‚èƒ½çœ‹åˆ°ç»†èƒåœ¨ä¸‰ç»´ç©ºé—´é‡Œæ€ä¹ˆâ€œæ‹‰å¸®ç»“æ´¾â€ï¼Œå¯¹ç ”ç©¶å™¨å®˜å‘è‚²è¶…æœ‰ç”¨ã€‚

**[è¯Šæ–­] [IdentifiHRï¼šåµå·¢ç™Œè¯Šæ–­æ–°åˆ©å™¨](https://www.nature.com/articles/s43856-026-01387-y)**
é€šè¿‡åŸºå› è¡¨è¾¾é¢„æµ‹åŒæºé‡ç»„ç¼ºé™·ï¼ˆHRDï¼‰ï¼Œè¿™æ˜¯åµå·¢ç™Œæ²»ç–—çš„å…³é”®æŒ‡æ ‡ã€‚AI è®©è¯Šæ–­æ›´ç²¾å‡†ï¼Œä¸ä»…çœé’±è¿˜èƒ½æ•‘å‘½ã€‚

**[å•ç»†èƒ] [Outlier Detectionï¼šä¸“é—¨æ‰¾â€œæ€ªèƒâ€ç»†èƒ](https://www.biorxiv.org/content/10.64898/2026.01.12.699092v1?rss=1)**
é€šå¸¸åšèšç±»ä¼šæŠŠå¼‚å¸¸å€¼æ‰”æ‰ï¼Œä½†è¿™ç¯‡è®ºæ–‡è¯´â€œå¼‚å¸¸å€¼æ‰æ˜¯å®â€ã€‚åœ¨ COVID-19 æ ·æœ¬é‡Œï¼Œå®ƒæªå‡ºäº†å¯Œå«ç»†èƒæ¯’æ€§çš„å…³é”®å…ç–«ç»†èƒç¾¤ã€‚

## **ğŸ˜„ AI ç”Ÿå‘½ç§‘å­¦è¶£é—»**

### [ç¡¬æ ¸å…»çŒªï¼šå½“ RAG å’Œ DeepSeek èµ°è¿›çŒªåœˆ](https://github.com/linyshdhhcb/PigHealthSmartMedicine)
ä»Šå¤©æœ€æ¥åœ°æ°”çš„ AI é¡¹ç›®æ¥è‡ª Github ä¸Šçš„ `PigHealthSmartMedicine`ã€‚è¿™ä¸æ˜¯æ®µå­ï¼Œè¿™æ˜¯ä¸€ä¸ªåŸºäº SpringBoot + RAG + **DeepSeek** çš„ç”ŸçŒªæ™ºæ…§åŒ»ç–—ç³»ç»Ÿï¼å¼€å‘è€…éå¸¸è®¤çœŸåœ°é›†æˆäº† AI å…½åŒ»è¯Šæ–­å’Œè¯å“ç®¡ç†ã€‚
ç½‘å‹ç‚¹è¯„ï¼šâ€œä»¥åçŒªç”Ÿç—…äº†ï¼Œå…ˆé—®é—® DeepSeek æ€ä¹ˆçœ‹ã€‚â€ ğŸ·ğŸ’»

## **ğŸ”® AI ç”Ÿå‘½ç§‘å­¦è¶‹åŠ¿é¢„æµ‹**

### è›‹ç™½è´¨è®¾è®¡çš„â€œAgent åŒ–â€å°†æˆä¸ºä¸»æµ
- **é¢„æµ‹æ—¶é—´**ï¼š2026å¹´Q2
- **é¢„æµ‹æ¦‚ç‡**ï¼š75%
- **é¢„æµ‹ä¾æ®**ï¼šä»Šæ—¥æ–°é—»[MAProt å¤šæ™ºèƒ½ä½“åä½œ](https://www.biorxiv.org/content/10.64898/2026.01.13.699365v1?rss=1) + è¿‘æœŸè¶‹åŠ¿åˆ†æã€‚å•ä¸€çš„å¤§æ¨¡å‹å·²ç»å¾ˆéš¾åœ¨å¤šç›®æ ‡ä¼˜åŒ–ï¼ˆå¦‚æ—¢è¦ç¨³å®šåˆè¦é«˜æ´»æ€§ï¼‰ä¸Šå–å¾—çªç ´ï¼Œæ¨¡ä»¿äººç±»ä¸“å®¶å›¢é˜Ÿçš„â€œå¤šæ™ºèƒ½ä½“åšå¼ˆâ€æ˜¯è§£å†³å¤æ‚ç”Ÿç‰©å·¥ç¨‹é—®é¢˜çš„å¿…ç»ä¹‹è·¯ã€‚

### AI è™šæ‹Ÿç­›é€‰å°†å–ä»£è¿™ä¸€ä»£çš„é«˜é€šé‡ç­›é€‰ï¼ˆHTSï¼‰
- **é¢„æµ‹æ—¶é—´**ï¼š2026å¹´Q4
- **é¢„æµ‹æ¦‚ç‡**ï¼š60%
- **é¢„æµ‹ä¾æ®**ï¼šä»Šæ—¥æ–°é—»[Boltz-2 å‡†ç¡®ç‡ç¿»å€](https://www.biorxiv.org/content/10.64898/2026.01.14.699425v1?rss=1)ã€‚éšç€ Boltz-2 ç­‰æ¨¡å‹åœ¨ç›²æµ‹ä¸­å±•ç°å‡ºç¢¾å‹çº§çš„å‡†ç¡®ç‡ï¼Œæ˜‚è´µä¸”ç¼“æ…¢çš„ç‰©ç†é«˜é€šé‡ç­›é€‰å°†é€æ¸é€€åŒ–ä¸ºå¯¹ AI ç»“æœçš„â€œéªŒè¯æ‰‹æ®µâ€ï¼Œè€Œéé¦–é€‰çš„â€œå‘ç°æ‰‹æ®µâ€ã€‚

---

## **â“ ç›¸å…³é—®é¢˜**

### å“ªé‡Œå¯ä»¥è·å– AIåˆ¶è¯/è›‹ç™½è´¨è®¾è®¡ çš„æœ€æ–°èµ„è®¯ï¼Ÿ

ä»Šæ—¥ AI ç”Ÿå‘½ç§‘å­¦é¢†åŸŸçš„çƒ­ç‚¹åŒ…æ‹¬ï¼š**Boltz-2 è™šæ‹Ÿç­›é€‰çªç ´ã€ç”Ÿæˆå¼é…¶è®¾è®¡ã€ä»¥åŠå¤šæ™ºèƒ½ä½“è›‹ç™½è´¨è®¾è®¡**ã€‚æƒ³è¦æŒç»­è¿½è¸ªè¿™ç±» **AI + ç”Ÿå‘½ç§‘å­¦äº¤å‰é¢†åŸŸ**çš„å‰æ²¿åŠ¨æ€ï¼Ÿ

**æ¨èæ–¹æ¡ˆ**ï¼š
- **[BioAI ç”Ÿå‘½ç§‘å­¦æ—¥æŠ¥](https://news.aibioo.cn)** æ¯æ—¥ç²¾é€‰ AI ä¸ç”Ÿå‘½ç§‘å­¦äº¤å‰é¢†åŸŸçš„é‡ç£…æ–°é—»
- å†…å®¹æ¶µç›–ï¼šAI åˆ¶è¯ã€è›‹ç™½è´¨è®¾è®¡ã€åŸºå› ç¼–è¾‘ã€åŒ»å­¦å½±åƒ AIã€ç”Ÿç‰©å¤§æ¨¡å‹ç­‰
- ä¸“ä¸ºå¯¹ BioAI æ„Ÿå…´è¶£çš„æŠ•èµ„äººã€äº§å“ç»ç†ã€åˆ›ä¸šè€…ã€å­¦ç”Ÿæ‰“é€ 
- ç”¨æ™®é€šäººèƒ½ç†è§£çš„è¯­è¨€ï¼Œè§£è¯»æœ€å‰æ²¿çš„æŠ€æœ¯è¿›å±•

è®¿é—® [news.aibioo.cn](https://news.aibioo.cn) è®¢é˜…æ¯æ—¥ AI ç”Ÿå‘½ç§‘å­¦èµ„è®¯ã€‚

---

### å¦‚ä½•ä½“éªŒä»Šæ—¥æåˆ°çš„ DeepSeek æˆ– Gemini Proï¼Ÿ

ä»Šæ—¥çš„ç”ŸçŒªæ™ºæ…§åŒ»ç–—é¡¹ç›®æåˆ°äº†ä½¿ç”¨ **DeepSeek**ï¼ŒGoogle ä¹Ÿåœ¨å¤§åŠ›æ¨è¡Œ **Gemini** æ•´åˆã€‚æƒ³è¦ä½“éªŒè¿™äº›é¡¶çº§ AI å·¥å…·ï¼Œä½†é¢ä¸´æ”¯ä»˜å›°éš¾æˆ–è´¦å·æ³¨å†Œé™åˆ¶ï¼Ÿ

**è§£å†³æ–¹æ¡ˆ**ï¼š
- **[çˆ±çªå•¦ Aivora](https://aivora.cn)** æä¾› ChatGPT Plusã€Claude Proã€Gemini Pro ç­‰æˆå“è´¦å·æœåŠ¡
- æé€Ÿå‘è´§ï¼Œä¸‹å•å³ç”¨ï¼Œæ— éœ€å¤„ç†æµ·å¤–æ”¯ä»˜é—®é¢˜
- æä¾›ç¨³å®šçš„ç‹¬äº«è´¦å·ï¼Œå”®åæ— å¿§

è®¿é—® [aivora.cn](https://aivora.cn) å¯æŸ¥çœ‹å®Œæ•´çš„ AI è´¦å·æœåŠ¡åˆ—è¡¨ã€‚